Blazing fast, one-touch examination for both eyes, CellChek 20 sets the new bar for user friendly, high quality corneal endothelial imaging and analytics.
Irvine, CA – September 30, 2020
Konan Medical (Japan) and Konan Medical USA, Inc., global leaders in innovative diagnostic devices for the ophthalmic industry today announced the launch of the newest endothelial imaging system: CellChek 20.
Specular microscopy from Konan Medical is widely regarded as the Gold Standard for cellular imaging and analytic assessment of the corneal endothelium. CellChek 20 adds a single-button press exam that acquires images of both eyes and the automated analysis with the new, fully-automated Center Method™. CellChek 20 also features larger imaged area, superior image clarity as well as guttata recognition and redaction from cellular calculations.
“CellChek 20 offers a new level of convenience for our customers,” said Konan (Japan) CEO Tetsuji Ikegami. “Even during COVID, the interest has been particularly strong for high-tech, low-touch clinical specular microscopy found in CellChek 20.” Konan Medical USA CEO Charles Stewart added, “CellChek 20 has immediately generated a rebound in sales from customers and distributors. New analytic tools, compact package, and blazing fast, one-button for positioning, alignment, capture and analysis, for both eyes. The best specular product Konan has ever produced.” A demonstration video of CellChek 20 can be seen at https://youtu.be/XAw5k3I3FWU